PPD

FEBRUARY 12, 2025

Its important for your clinical research organization (CRO) to continually assess and invest in capabilities that help drive the success of your clinical program. There are three core areas we are strategically addressing this year. They include: 1.

Clinical Supply 69

Clinical Supply Clinical Trials Drug Development Clinical Research 69

PPD

SEPTEMBER 6, 2023

Approaches to outsourcing clinical trials have changed significantly in recent years. Mixing of service models — a strategy that drug developers are leveraging now more than ever — can bring life-changing therapies to market faster. Often working directly within client’s systems and SOPs.

Drug Development 98

Drug Development Clinical Trials Drugs Clinical Research 98

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Enrolling study subjects, setting up patient randomization and managing drug supply are critical to the success of a clinical trial. .

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Alta Sciences

DECEMBER 14, 2023

Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study. . - Fully equipped to support all types of IP administration forms.

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

The Pharma Data

OCTOBER 27, 2020

The collaboration aims to leverage Molecular Partners’ proprietary DARPin® technologies and Novartis’ broad expertise in global drug development, regulatory affairs, manufacturing and commercialization to rapidly advance the program in keeping with the unprecedented global urgency created by the pandemic.

Therapies 40

Therapies Virus Treatment Clinical Trials 40

PPD

FEBRUARY 3, 2025

In todays clinical research landscape, it is both essential and challenging to accelerate clinical trials. However, achieving this requires drug developers to navigate a highly complex and competitive environment. The challenges are compounded by increasing trial complexities.

Clinical Trials 52

Clinical Trials Trials Clinical Supply Drug Development 52